BetaLife

BetaLife's founding team combines accomplished scientists with extensive experience in stem cells and diabetes, along with a strong business and commercialization team. BetaLife is jointly committed to translating stem cell technology into therapeutic applications.BetaLife aims to develop high-quality, stem cell-based regenerative treatment solutions for diabetes. BetaLife's core technology was developed at the Agency for Science, Technology and Research (A*STAR) in Singapore.BetaLife has its own state-of-the-art laboratory facilities in downtown Singapore, with R&D and cell manufacturing capabilities.